Document is current
Any future updates will be listed below
-
Authors
Cortellini, Alessio https://orcid.org/0000-0002-1209-5735
Bersanelli, Melissa
Buti, Sebastiano
Cannita, Katia
Santini, Daniele
Perrone, Fabiana
Giusti, Raffaele
Tiseo, Marcello
Michiara, Maria
Di Marino, Pietro
Tinari, Nicola
De Tursi, Michele
Zoratto, Federica
Veltri, Enzo
Marconcini, Riccardo
Malorgio, Francesco
Russano, Marco
Anesi, Cecilia
Zeppola, Tea
Filetti, Marco
Marchetti, Paolo
Botticelli, Andrea
Antonini Cappellini, Gian Carlo
De Galitiis, Federica
Vitale, Maria Giuseppa
Rastelli, Francesca
Pergolesi, Federica
Berardi, Rossana
Rinaldi, Silvia
Tudini, Marianna
Silva, Rosa Rita
Pireddu, Annagrazia
Atzori, Francesco
Chiari, Rita
Ricciuti, Biagio
De Giglio, Andrea
Iacono, Daniela
Gelibter, Alain
Occhipinti, Mario Alberto
Parisi, Alessandro
Porzio, Giampiero
Fargnoli, Maria Concetta
Ascierto, Paolo Antonio
Ficorella, Corrado
Natoli, Clara
-
More Information
Article History
Received: 4 December 2018
Accepted: 5 February 2019
First Online: 27 February 2019
Ethics approval and consent to participate
: All patients provided written, informed consent to treatment with immunotherapy. All patients alive at the time of data collection provided an informed consent for the present retrospective analysis. The procedures followed were in accordance with the precepts of Good Clinical Practice and the declaration of Helsinki. The study was approved by the respective local ethical committees on human experimentation of each institution, after previous approval by the coordinating center (University of L’Aquila, Internal Review Board protocol number 32865, approved on July 24, 2018).
: Not applicable.
: Dr Alessio Cortellini received grants as speaker by MSD, Astra-Zeneca and Boehringer Ingelheim, gran consultancies by BMS and Ipsen; dr Marcello Tiseo received grant as speaker and advisory role by Astra-Zeneca, Pfizer, Eli-Lilly, BMS, Novartis, Roche, MSD, Boehringer Ingelheim, Otsuka, Pierre Fabre; dr Maria Giuseppa Vitale received travel grants and speaker fees by BMS, Ipsen Astellas, Jansen, Novartis and Pfizer; dr Sebatiano Buti received grants as speaker and advisory role by BMS, Pfizer, MSD, Ipsen, Novartis, Astra-Zeneca; dr. Melissa Bersanelli received honoraria as speaker at scientific events and as consultant for advisory role by BMS and Pfizer.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
